BAKER BROS ADVISORS LLC Insider Trading $GHDX GENOMIC HEALTH INC
Get free email notifications about insider trading for BAKER BROS ADVISORS LLC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of BAKER BROS ADVISORS LLC. BAKER BROS ADVISORS LLC is 10% Owner in BIOCRYST PHARMACEUTICALS INC ($BCRX) and Director in INCYTE CORP ($INCY) and Director in ALEXION PHARMACEUTICALS INC ($ALXN) and 10% Owner in IDERA PHARMACEUTICALS, INC. ($IDRA) and Director in IDERA PHARMACEUTICALS, INC. ($IDRA) and in XOMA Corp ($XOMA) and Director in ACADIA PHARMACEUTICALS INC ($ACAD) and Director in SEATTLE GENETICS INC /WA ($SGEN) and Director in GENOMIC HEALTH INC ($GHDX) and 10% Owner in BELLICUM PHARMACEUTICALS, INC ($BLCM) and 10% Owner in AQUINOX PHARMACEUTICALS, INC ($AQXP) and Director in AQUINOX PHARMACEUTICALS, INC ($AQXP) and Director in Zymeworks Inc. ($ZYME) and Director in Kodiak Sciences Inc. ($KOD) and 10% Owner in Invitae Corp ($NVTA) and Director in IGM Biosciences, Inc. ($IGMS) and 10% Owner in Atreca, Inc. ($BCEL) and in Mirati Therapeutics, Inc. ($MYG) and 10% Owner in Mirati Therapeutics, Inc. ($MYG) and Director in Talis Biomedical Corp ($TLIS) and Director in Aeglea BioTherapeutics, Inc. ($AGLE) and in RHYTHM PHARMACEUTICALS, INC. ($RYTM) and in Intellia Therapeutics, Inc. ($NTLA) and Director in BeiGene, Ltd. ($BGNE) and Director in Prelude Therapeutics Inc ($PRLD) and Director in Kiniksa Pharmaceuticals, Ltd. ($KNSA) and in HOOKIPA Pharma Inc. ($HOOK).
BAKER BROS ADVISORS LLC in GENOMIC HEALTH INC
Trading Symbol: GHDXIndustry: SERVICES-MEDICAL LABORATORIES [8071]
Position of BAKER BROS ADVISORS LLC: Director
Holdings: 165,980 shares
Current Value: $4,562,790
Latest Transaction: Oct 03 2019
$GHDX Market Capitalization: $928.37M
$GHDX Previous Close: $27.49
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of BAKER BROS ADVISORS LLC in GENOMIC HEALTH INC
Sentiment: All, ACAD, AGLE, ALXN, BCEL, BGNE, BLCM, BCRX, GHDX, HOOK, IDRA, IGMS, INCY, NTLA, NVTA, KNSA, KOD, MYG, NLTX, PRLD, RYTM, SGEN, TLIS, XOMA, ZYME
Page: < prev 1 2 3 4 5 5 next >
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Mar 19 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 74.50 | 6,467 | 481,792 | 1,373,699 | 1.4 M to 1.4 M (-0.47 %) |
Mar 19 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 74.50 | 1,115 | 83,068 | 269,074 | 270.2 K to 269.1 K (-0.41 %) |
Mar 19 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 74.50 | 647 | 48,202 | 173,157 | 173.8 K to 173.2 K (-0.37 %) |
Mar 19 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 74.50 | 49 | 3,651 | 50,808 | 50.9 K to 50.8 K (-0.10 %) |
Mar 19 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 74.50 | 722 | 53,789 | 188,587 | 189.3 K to 188.6 K (-0.38 %) |
Mar 19 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 76.57 | 3,068 | 234,915 | 8,719,547 | 8.7 M to 8.7 M (-0.04 %) |
Mar 19 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 76.57 | 471 | 36,064 | 1,380,166 | 1.4 M to 1.4 M (-0.03 %) |
Mar 19 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 76.57 | 81 | 6,202 | 270,189 | 270.3 K to 270.2 K (-0.03 %) |
Mar 19 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 76.57 | 47 | 3,599 | 173,804 | 173.9 K to 173.8 K (-0.03 %) |
Mar 19 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 76.57 | 4 | 306 | 50,857 | 50.9 K to 50.9 K (-0.01 %) |
Mar 19 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 76.57 | 52 | 3,982 | 189,309 | 189.4 K to 189.3 K (-0.03 %) |
Mar 14 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 76.03 | 1,648 | 125,301 | 8,722,615 | 8.7 M to 8.7 M (-0.02 %) |
Mar 14 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 76.03 | 253 | 19,236 | 1,380,637 | 1.4 M to 1.4 M (-0.02 %) |
Mar 14 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 76.03 | 44 | 3,345 | 270,270 | 270.3 K to 270.3 K (-0.02 %) |
Mar 14 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 76.03 | 25 | 1,901 | 173,851 | 173.9 K to 173.9 K (-0.01 %) |
Mar 14 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 76.03 | 2 | 152 | 50,861 | 50.9 K to 50.9 K (0.00 %) |
Mar 14 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 76.03 | 28 | 2,129 | 189,361 | 189.4 K to 189.4 K (-0.01 %) |
Mar 14 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 76.50 | 51,987 | 3,977,031 | 8,724,263 | 8.8 M to 8.7 M (-0.59 %) |
Mar 14 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 76.50 | 7,982 | 610,627 | 1,380,890 | 1.4 M to 1.4 M (-0.57 %) |
Mar 14 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 76.50 | 1,375 | 105,188 | 270,314 | 271.7 K to 270.3 K (-0.51 %) |
Mar 14 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 76.50 | 798 | 61,047 | 173,876 | 174.7 K to 173.9 K (-0.46 %) |
Mar 14 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 76.50 | 61 | 4,667 | 50,863 | 50.9 K to 50.9 K (-0.12 %) |
Mar 14 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 76.50 | 891 | 68,162 | 189,389 | 190.3 K to 189.4 K (-0.47 %) |
Mar 14 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 75.40 | 247 | 18,624 | 8,776,250 | 8.8 M to 8.8 M (0.00 %) |
Mar 14 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 75.40 | 39 | 2,941 | 1,388,872 | 1.4 M to 1.4 M (0.00 %) |
Mar 14 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 75.40 | 7 | 528 | 271,689 | 271.7 K to 271.7 K (0.00 %) |
Mar 14 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 75.40 | 4 | 302 | 174,674 | 174.7 K to 174.7 K (0.00 %) |
Mar 14 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 75.40 | 1 | 75 | 50,924 | 50.9 K to 50.9 K (0.00 %) |
Mar 14 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 75.40 | 4 | 302 | 190,280 | 190.3 K to 190.3 K (0.00 %) |
Mar 14 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 75.92 | 63,047 | 4,786,390 | 8,776,497 | 8.8 M to 8.8 M (-0.71 %) |
Mar 14 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 75.92 | 9,679 | 734,808 | 1,388,911 | 1.4 M to 1.4 M (-0.69 %) |
Mar 14 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 75.92 | 1,668 | 126,631 | 271,696 | 273.4 K to 271.7 K (-0.61 %) |
Mar 14 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 75.92 | 967 | 73,413 | 174,678 | 175.6 K to 174.7 K (-0.55 %) |
Mar 14 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 75.92 | 73 | 5,542 | 50,925 | 51 K to 50.9 K (-0.14 %) |
Mar 14 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 75.92 | 1,080 | 81,991 | 190,284 | 191.4 K to 190.3 K (-0.56 %) |
Mar 14 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 76.05 | 2,832 | 215,369 | 8,839,544 | 8.8 M to 8.8 M (-0.03 %) |
Mar 14 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 76.05 | 435 | 33,081 | 1,398,590 | 1.4 M to 1.4 M (-0.03 %) |
Mar 14 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 76.05 | 75 | 5,704 | 273,364 | 273.4 K to 273.4 K (-0.03 %) |
Mar 14 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 76.05 | 43 | 3,270 | 175,645 | 175.7 K to 175.6 K (-0.02 %) |
Mar 14 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 76.05 | 3 | 228 | 50,998 | 51 K to 51 K (-0.01 %) |
Mar 14 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 76.05 | 49 | 3,726 | 191,364 | 191.4 K to 191.4 K (-0.03 %) |
Mar 14 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 75.63 | 61,122 | 4,622,669 | 8,842,376 | 8.9 M to 8.8 M (-0.69 %) |
Mar 14 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 75.63 | 9,384 | 709,714 | 1,399,025 | 1.4 M to 1.4 M (-0.67 %) |
Mar 14 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 75.63 | 1,618 | 122,370 | 273,439 | 275.1 K to 273.4 K (-0.59 %) |
Mar 14 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 75.63 | 938 | 70,941 | 175,688 | 176.6 K to 175.7 K (-0.53 %) |
Mar 14 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 75.63 | 71 | 5,370 | 51,001 | 51.1 K to 51 K (-0.14 %) |
Mar 14 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 75.63 | 1,047 | 79,185 | 191,413 | 192.5 K to 191.4 K (-0.54 %) |
Mar 11 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 74.03 | 3,296 | 244,007 | 8,903,498 | 8.9 M to 8.9 M (-0.04 %) |
Mar 11 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 74.03 | 506 | 37,460 | 1,408,409 | 1.4 M to 1.4 M (-0.04 %) |
Mar 11 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 74.03 | 87 | 6,441 | 275,057 | 275.1 K to 275.1 K (-0.03 %) |
Mar 11 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 74.03 | 51 | 3,776 | 176,626 | 176.7 K to 176.6 K (-0.03 %) |
Mar 11 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 74.03 | 4 | 296 | 51,072 | 51.1 K to 51.1 K (-0.01 %) |
Mar 11 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 74.03 | 56 | 4,146 | 192,460 | 192.5 K to 192.5 K (-0.03 %) |
Mar 11 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 75.08 | 37,107 | 2,786,101 | 8,906,794 | 8.9 M to 8.9 M (-0.41 %) |
Mar 11 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 75.08 | 5,697 | 427,747 | 1,408,915 | 1.4 M to 1.4 M (-0.40 %) |
Mar 11 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 75.08 | 982 | 73,731 | 275,144 | 276.1 K to 275.1 K (-0.36 %) |
Mar 11 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 75.08 | 569 | 42,722 | 176,677 | 177.2 K to 176.7 K (-0.32 %) |
Mar 11 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 75.08 | 43 | 3,229 | 51,076 | 51.1 K to 51.1 K (-0.08 %) |
Mar 11 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 75.08 | 637 | 47,828 | 192,516 | 193.2 K to 192.5 K (-0.33 %) |
Mar 11 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 73.55 | 18,703 | 1,375,551 | 8,943,901 | 9 M to 8.9 M (-0.21 %) |
Mar 11 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 73.55 | 2,872 | 211,227 | 1,414,612 | 1.4 M to 1.4 M (-0.20 %) |
Mar 11 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 73.55 | 495 | 36,406 | 276,126 | 276.6 K to 276.1 K (-0.18 %) |
Mar 11 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 73.55 | 287 | 21,108 | 177,246 | 177.5 K to 177.2 K (-0.16 %) |
Mar 11 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 73.55 | 22 | 1,618 | 51,119 | 51.1 K to 51.1 K (-0.04 %) |
Mar 11 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 73.55 | 321 | 23,609 | 193,153 | 193.5 K to 193.2 K (-0.17 %) |
Mar 11 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 73.72 | 1,647 | 121,421 | 8,962,604 | 9 M to 9 M (-0.02 %) |
Mar 11 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 73.72 | 253 | 18,652 | 1,417,484 | 1.4 M to 1.4 M (-0.02 %) |
Mar 11 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 73.72 | 44 | 3,244 | 276,621 | 276.7 K to 276.6 K (-0.02 %) |
Mar 11 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 73.72 | 25 | 1,843 | 177,533 | 177.6 K to 177.5 K (-0.01 %) |
Mar 11 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 73.72 | 2 | 147 | 51,141 | 51.1 K to 51.1 K (0.00 %) |
Mar 11 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 73.72 | 29 | 2,138 | 193,474 | 193.5 K to 193.5 K (-0.01 %) |
Feb 28 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 76.20 | 493 | 37,565 | 9,060,972 | 9.1 M to 9.1 M (-0.01 %) |
Feb 28 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 76.20 | 76 | 5,791 | 1,432,586 | 1.4 M to 1.4 M (-0.01 %) |
Feb 28 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 76.20 | 13 | 991 | 279,226 | 279.2 K to 279.2 K (0.00 %) |
Feb 28 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 76.20 | 8 | 610 | 179,043 | 179.1 K to 179 K (0.00 %) |
Feb 28 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 76.20 | 1 | 76 | 51,256 | 51.3 K to 51.3 K (0.00 %) |
Feb 28 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 76.20 | 9 | 686 | 195,161 | 195.2 K to 195.2 K (0.00 %) |
Feb 28 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Option Exercise | M | 17.59 | 8,250 | 145,118 | 0 | |
Feb 28 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Option Exercise | M | 17.59 | 8,250 | 145,118 | 0 | |
Feb 28 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 76.20 | 742 | 56,540 | 9,061,465 | 9.1 M to 9.1 M (-0.01 %) |
Feb 28 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 76.20 | 114 | 8,687 | 1,432,662 | 1.4 M to 1.4 M (-0.01 %) |
Feb 28 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 76.20 | 20 | 1,524 | 279,239 | 279.3 K to 279.2 K (-0.01 %) |
Feb 28 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 76.20 | 11 | 838 | 179,051 | 179.1 K to 179.1 K (-0.01 %) |
Feb 28 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 76.20 | 1 | 76 | 51,257 | 51.3 K to 51.3 K (0.00 %) |
Feb 28 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 76.20 | 13 | 991 | 195,170 | 195.2 K to 195.2 K (-0.01 %) |
Feb 28 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 76.66 | 31,482 | 2,413,501 | 9,062,207 | 9.1 M to 9.1 M (-0.35 %) |
Feb 28 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 76.66 | 4,833 | 370,512 | 1,432,776 | 1.4 M to 1.4 M (-0.34 %) |
Feb 28 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 76.66 | 833 | 63,860 | 279,259 | 280.1 K to 279.3 K (-0.30 %) |
Feb 28 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 76.66 | 484 | 37,105 | 179,062 | 179.5 K to 179.1 K (-0.27 %) |
Feb 28 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 76.66 | 37 | 2,837 | 51,258 | 51.3 K to 51.3 K (-0.07 %) |
Feb 28 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 76.66 | 539 | 41,321 | 195,183 | 195.7 K to 195.2 K (-0.28 %) |
Feb 28 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 77.81 | 620 | 48,239 | 9,093,689 | 9.1 M to 9.1 M (-0.01 %) |
Feb 28 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 77.81 | 95 | 7,392 | 1,437,609 | 1.4 M to 1.4 M (-0.01 %) |
Feb 28 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 77.81 | 16 | 1,245 | 280,092 | 280.1 K to 280.1 K (-0.01 %) |
Feb 28 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 77.81 | 10 | 778 | 179,546 | 179.6 K to 179.5 K (-0.01 %) |
Feb 28 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 77.81 | 1 | 78 | 51,295 | 51.3 K to 51.3 K (0.00 %) |
Feb 28 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 77.81 | 11 | 856 | 195,722 | 195.7 K to 195.7 K (-0.01 %) |
Feb 28 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 78.13 | 6,506 | 508,342 | 9,094,309 | 9.1 M to 9.1 M (-0.07 %) |
Feb 28 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 78.13 | 999 | 78,056 | 1,437,704 | 1.4 M to 1.4 M (-0.07 %) |
Feb 28 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 78.13 | 172 | 13,439 | 280,108 | 280.3 K to 280.1 K (-0.06 %) |
Feb 28 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 78.13 | 100 | 7,813 | 179,556 | 179.7 K to 179.6 K (-0.06 %) |
Feb 28 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 78.13 | 8 | 625 | 51,296 | 51.3 K to 51.3 K (-0.02 %) |
Feb 28 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 78.13 | 112 | 8,751 | 195,733 | 195.8 K to 195.7 K (-0.06 %) |
Feb 28 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Buy | M | 17.59 | 8,250 | 145,118 | 9,100,815 | 9.1 M to 9.1 M (+0.09 %) |
Feb 28 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Buy | M | 17.59 | 8,250 | 145,118 | 1,438,703 | 1.4 M to 1.4 M (+0.58 %) |
Jan 30 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 70.55 | 13,634 | 961,887 | 9,092,565 | 9.1 M to 9.1 M (-0.15 %) |
Jan 30 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 70.55 | 2,093 | 147,662 | 1,430,453 | 1.4 M to 1.4 M (-0.15 %) |
Jan 30 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 70.55 | 361 | 25,469 | 280,280 | 280.6 K to 280.3 K (-0.13 %) |
Jan 30 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 70.55 | 210 | 14,816 | 179,656 | 179.9 K to 179.7 K (-0.12 %) |
Jan 30 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 70.55 | 16 | 1,129 | 51,304 | 51.3 K to 51.3 K (-0.03 %) |
Jan 30 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 70.55 | 234 | 16,509 | 195,845 | 196.1 K to 195.8 K (-0.12 %) |
Jan 30 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 71.35 | 24,660 | 1,759,553 | 9,106,199 | 9.1 M to 9.1 M (-0.27 %) |
Jan 30 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 71.35 | 3,786 | 270,141 | 1,432,546 | 1.4 M to 1.4 M (-0.26 %) |
Jan 30 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 71.35 | 653 | 46,593 | 280,641 | 281.3 K to 280.6 K (-0.23 %) |
Jan 30 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 71.35 | 378 | 26,971 | 179,866 | 180.2 K to 179.9 K (-0.21 %) |
Jan 30 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 71.35 | 29 | 2,069 | 51,320 | 51.3 K to 51.3 K (-0.06 %) |
Jan 30 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 71.35 | 423 | 30,182 | 196,079 | 196.5 K to 196.1 K (-0.22 %) |
Jan 25 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 72.20 | 75,736 | 5,468,397 | 9,130,859 | 9.2 M to 9.1 M (-0.82 %) |
Jan 25 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 72.20 | 11,627 | 839,509 | 1,436,332 | 1.4 M to 1.4 M (-0.80 %) |
Jan 25 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 72.20 | 2,004 | 144,696 | 281,294 | 283.3 K to 281.3 K (-0.71 %) |
Jan 25 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 72.20 | 1,162 | 83,900 | 180,244 | 181.4 K to 180.2 K (-0.64 %) |
Jan 25 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 72.20 | 89 | 6,426 | 51,349 | 51.4 K to 51.3 K (-0.17 %) |
Jan 25 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 72.20 | 1,298 | 93,720 | 196,502 | 197.8 K to 196.5 K (-0.66 %) |
Jan 25 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 72.02 | 65,426 | 4,711,967 | 9,206,595 | 9.3 M to 9.2 M (-0.71 %) |
Jan 25 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 72.02 | 10,044 | 723,367 | 1,447,959 | 1.5 M to 1.4 M (-0.69 %) |
Jan 25 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 72.02 | 1,732 | 124,738 | 283,298 | 285 K to 283.3 K (-0.61 %) |
Jan 25 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 72.02 | 1,004 | 72,308 | 181,406 | 182.4 K to 181.4 K (-0.55 %) |
Jan 25 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 72.02 | 76 | 5,474 | 51,438 | 51.5 K to 51.4 K (-0.15 %) |
Jan 25 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 72.02 | 1,121 | 80,734 | 197,800 | 198.9 K to 197.8 K (-0.56 %) |
Jan 25 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 73.46 | 1,648 | 121,054 | 9,272,021 | 9.3 M to 9.3 M (-0.02 %) |
Jan 25 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 73.46 | 253 | 18,584 | 1,458,003 | 1.5 M to 1.5 M (-0.02 %) |
Jan 25 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 73.46 | 44 | 3,232 | 285,030 | 285.1 K to 285 K (-0.02 %) |
Jan 25 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 73.46 | 25 | 1,836 | 182,410 | 182.4 K to 182.4 K (-0.01 %) |
Jan 25 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 73.46 | 2 | 147 | 51,514 | 51.5 K to 51.5 K (0.00 %) |
Jan 25 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 73.46 | 28 | 2,057 | 198,921 | 198.9 K to 198.9 K (-0.01 %) |
Jan 25 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 70.52 | 29,260 | 2,063,313 | 9,273,669 | 9.3 M to 9.3 M (-0.31 %) |
Jan 25 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 70.52 | 4,492 | 316,760 | 1,458,256 | 1.5 M to 1.5 M (-0.31 %) |
Jan 25 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 70.52 | 774 | 54,580 | 285,074 | 285.8 K to 285.1 K (-0.27 %) |
Jan 25 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 70.52 | 450 | 31,732 | 182,435 | 182.9 K to 182.4 K (-0.25 %) |
Jan 25 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 70.52 | 34 | 2,398 | 51,516 | 51.6 K to 51.5 K (-0.07 %) |
Jan 25 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 70.52 | 502 | 35,399 | 198,949 | 199.5 K to 198.9 K (-0.25 %) |
Jan 22 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 71.00 | 42,521 | 3,018,995 | 9,302,929 | 9.3 M to 9.3 M (-0.45 %) |
Jan 22 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 71.00 | 6,529 | 463,560 | 1,462,748 | 1.5 M to 1.5 M (-0.44 %) |
Jan 22 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 71.00 | 1,125 | 79,875 | 285,848 | 287 K to 285.8 K (-0.39 %) |
Jan 22 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 71.00 | 652 | 46,292 | 182,885 | 183.5 K to 182.9 K (-0.36 %) |
Jan 22 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 71.00 | 50 | 3,550 | 51,550 | 51.6 K to 51.6 K (-0.10 %) |
Jan 22 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 71.00 | 729 | 51,759 | 199,451 | 200.2 K to 199.5 K (-0.36 %) |
Jan 22 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 71.61 | 10,547 | 755,298 | 9,345,450 | 9.4 M to 9.3 M (-0.11 %) |
Jan 22 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 71.61 | 1,619 | 115,941 | 1,469,277 | 1.5 M to 1.5 M (-0.11 %) |
Jan 22 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 71.61 | 279 | 19,980 | 286,973 | 287.3 K to 287 K (-0.10 %) |